Which federal agency does National Community Pharmacists Association comment on most?

National Community Pharmacists Association is most active at the Food and Drug Administration.

National Community Pharmacists Association

Unclaimed

Website

Engagement overview

National Community Pharmacists Association has filed 165 public comments across 137 dockets at 8 federal agencies, most actively at the Food and Drug Administration.

National Community Pharmacists Association

Engagement overview

Is this your organization?

Agency footprint

Dockets · CMS (29)

Secure Electronic Prior Authorization for Part D Drugs CMS-4189-P

Request for Information: Reducing Administrative Burden to put Patients over Paperwork (CMS-6082-NC)

Medicaid and Children’s Health Insurance Plan (CHIP) Managed Care (CMS-2408-P)

Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, and Medicaid Managed Care Programs for Contract Year 2020 CMS-4185-P

Regulation to Require Drug Pricing Transparency CMS-4187-P

Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs For Contract Year 2019 CMS-4182-P

Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2019 (CMS-9930-P)

CY 2017 Notice of Benefit and Payment Parameters CMS-9937-P

Medicaid and Children’s Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability (CMS-2390-P)

CY 2016 Notice of Benefit and Payment Parameters CMS-9944-P

Medicare Program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (CMS-4159-P)

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P)

Medicare Program; Proposed Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2013 and Other Proposed Changes; Considering Changes to the Conditions of Participation for Long Term Care Facilities

Reporting and Returning of Overpayments

Medicaid Program; Covered Outpatient Drugs (CMS-2345-IFC2)

Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2012

Medicare and Medicaid Programs; Opportunities for Alignment under Medicaid and Medicare (CMS-5507-NC)

Medicare Program; Accountable Care Organizations and the Medicare Shared Saving Program

Medicare Program: Solicitation of Comments Regarding Development of a Recovery Audit Contractor Program for the Medicare Part C and D Programs

Recovery Audit Contractors

Medicare, Medicaid, and Children’s Health Insurance Programs; Additional Screening Requirements, Application Fees, Temporary Enrollment Moratoria Payment Suspensions and Compliance Plans for Providers and Suppliers

"Medicaid Program; Withdrawal of Determination of Average Manufacturer Price, Multiple Source Drug Definition, and Upper Limits for Multiple Source Drugs"

Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011

Medicare Program; Medicare Coverage Gap Discount Program Model Manufacturer Agreement and Announcement of the June 1, 2010 Public Meeting

Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs

Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E Prescribing Exemption for Computer Generated Facsimile Transmissions